83076-1025-3 : NDC 2026 Code

83076-1025-3 : Ensartinib ( Ensacove )

Additionally :

You can get information about “83076-1025-3” NDC code in 83076-1025-3 in HTML format

HTML | 83076-1025-3 in TXT (Plain Text) format

TXT | 83076-1025-3 in PDF (Portable Document Format)

PDF | 83076-1025-3 in XML format

XML formats.

NDC Code : 83076-1025-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "83076-1025-3",
    "PackageDescription": "30 CAPSULE in 1 BOTTLE (83076-1025-3) ",
    "NDC11Code": "83076-1025-03",
    "ProductNDC": "83076-1025",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ensacove",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ensartinib",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250430",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA218171",
    "LabelerName": "Xcovery Holdings, Inc.",
    "SubstanceName": "ENSARTINIB HYDROCHLORIDE",
    "StrengthNumber": "25",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-27",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20250430",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}